Research Use Only. The information presented here is for scientific and educational purposes. These compounds are not intended for human consumption, self-administration, or therapeutic use.
Introduction
Metabolic pathways, the interconnected systems that govern glucose handling, lipid processing, and cellular energy balance, are among the most intensively studied areas in modern peptide science. This overview surveys a group of metabolic peptides that appear frequently in the research literature: the incretin receptor research compounds GLP-1 SM, GLP-2 TZ, and GLP-3 RT, the amylin analog Cagrilintide, the mitochondrial-derived peptide MOTS-c, and the growth-hormone fragment AOD-9604. Each is discussed strictly in terms of the molecular targets and signaling pathways that laboratory investigations have associated with it.
Everything described below reflects preclinical, in-vitro, and animal-model research. No statement here should be read as a claim of human benefit, dosing guidance, or therapeutic outcome. These materials are supplied for research use only, not for human consumption. The biological backdrop for this work includes the incretin axis (the hormone signaling that links the gut to the pancreas), amylin signaling, the cellular energy sensor AMP-activated protein kinase (AMPK), and peptides encoded within mitochondrial DNA. Researchers reference these systems when characterizing how each compound behaves in controlled models. For handling and verification practices, laboratories typically consult a compound’s certificate of analysis; see our guide to reading a peptide COA.
Metabolic Signaling as a Research Target
The incretin axis
The incretin system describes hormones released from the intestine that influence pancreatic signaling in response to nutrient intake. Two receptors dominate this research area: the GLP-1 receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor. A third target, the glucagon receptor, is often studied alongside them because of its role in hepatic glucose output and lipid mobilization in preclinical models. Peptides that engage one, two, or all three of these receptors are characterized in cell assays and animal models to map downstream signaling, receptor selectivity, and pathway crosstalk.
Amylin and mitochondrial pathways
Beyond the incretin axis, metabolic peptide research examines amylin (a pancreatic hormone that signals through amylin and calcitonin receptor complexes) and the family of mitochondrial-derived peptides, short sequences encoded in mitochondrial DNA that appear to influence cellular energy regulation. A recurring node across these studies is AMPK, an enzyme that acts as a cellular fuel gauge. Interest in these pathways is grounded in basic biology, and the observations below come from laboratory systems rather than any applied human context.
Incretin Receptor Research Compounds
GLP-1 SM
GLP-1 SM is studied as a single-target GLP-1 receptor agonist analog. In laboratory research it serves as a reference compound for probing GLP-1 receptor binding, receptor internalization, and downstream signaling in pancreatic and neuronal cell models. Its acylated structure is associated with extended stability under study conditions. Product listing: GLP-1 SM.
GLP-2 TZ
GLP-2 TZ is investigated as a dual incretin receptor agonist, meaning it is characterized for activity at both the GIP and GLP-1 receptors. Researchers use dual-agonist compounds to study how simultaneous engagement of two incretin receptors alters signaling magnitude and receptor bias relative to single-target analogs. See GLP-2 TZ.
GLP-3 RT
GLP-3 RT extends the concept further and is studied as a triple receptor agonist with reported activity at the GIP, GLP-1, and glucagon receptors. Triple-agonist research explores how adding glucagon receptor engagement influences energy expenditure and lipid handling endpoints in preclinical models. Product page: GLP-3 RT.
Amylin, Mitochondrial, and Lipid-Fragment Peptides
Cagrilintide
Cagrilintide is a long-acting amylin analog studied for its interaction with amylin and calcitonin receptor complexes. In metabolic research it is frequently examined alongside incretin compounds to characterize combined signaling in animal models. Listing: Cagrilintide.
MOTS-c
MOTS-c is a mitochondrial-derived peptide of sixteen amino acids that has been studied for its association with AMPK activation and metabolic homeostasis in cell and rodent models. It is a frequent subject in research on how mitochondrial signaling communicates with the rest of the cell. See MOTS-c.
AOD-9604
AOD-9604 is a modified fragment derived from the C-terminal region of human growth hormone (residues 176 to 191). It has been investigated in vitro and in animal studies for its association with lipid metabolism pathways, independent of the growth-promoting activity of the intact hormone. Product page: AOD-9604.
Comparing Reported Attributes of Metabolic Peptides
The table below summarizes identity attributes that researchers commonly reference when distinguishing these compounds. The values reflect commonly reported laboratory attributes and are provided for comparison only.
| Compound | Research class | Approx. molecular weight (g/mol) | Approx. length (amino acids) | Primary pathway studied |
|---|---|---|---|---|
| GLP-1 SM | Single incretin (GLP-1 receptor) agonist analog | ~4,100 | ~31 | GLP-1 receptor signaling |
| GLP-2 TZ | Dual incretin (GIP and GLP-1) receptor agonist | ~4,800 | ~39 | GIP and GLP-1 receptor signaling |
| GLP-3 RT | Triple (GIP, GLP-1, glucagon) receptor agonist | ~4,700 | ~39 | Triple incretin and glucagon signaling |
| Cagrilintide | Long-acting amylin analog | ~3,700 | ~37 | Amylin and calcitonin receptor signaling |
| MOTS-c | Mitochondrial-derived peptide | ~2,174 | 16 | AMPK and mitochondrial signaling |
| AOD-9604 | Growth-hormone (176 to 191) fragment | ~1,815 | 16 | Lipid metabolism pathways |
Because coded and analog peptides can vary in reported purity and composition between suppliers, laboratories generally confirm identity and purity against third-party documentation before study use. Rejuven8 publishes batch certificates of analysis, and our full catalog of research peptides lists specifications for each item. For guidance on evaluating a supplier’s documentation, review our supplier vetting checklist.
Frequently Asked Questions
What are metabolic peptides in research?
In a research context, metabolic peptides are short protein sequences studied for their interaction with pathways that regulate glucose handling, lipid processing, and cellular energy balance. Examples characterized in the laboratory include incretin receptor compounds, amylin analogs, and mitochondrial-derived peptides. They are studied as molecular tools, not as products for human use.
Which peptides are studied in the GLP-1 receptor pathway?
GLP-1 SM is studied as a single GLP-1 receptor agonist analog, while GLP-2 TZ and GLP-3 RT engage the GLP-1 receptor as part of dual and triple receptor agonist profiles respectively. All three are examined in preclinical models to map receptor binding and downstream signaling.
What is the difference between single, dual, and triple incretin receptor agonists?
The distinction refers to how many incretin-related receptors a compound engages in laboratory assays. A single agonist targets one receptor (for example the GLP-1 receptor), a dual agonist targets two (GIP and GLP-1), and a triple agonist adds a third target (the glucagon receptor). Researchers compare these profiles to understand how receptor combinations change signaling in cell and animal models.
Is MOTS-c considered a metabolic peptide?
Yes. MOTS-c is a mitochondrial-derived peptide widely studied in metabolic research for its reported association with AMPK activation and cellular energy regulation. It is investigated in cell cultures and rodent models rather than in human applications.
What is AOD-9604 studied for?
AOD-9604 is a fragment of human growth hormone studied in vitro and in animal models for its association with lipid metabolism pathways. It is examined independently of the growth-promoting effects of the intact hormone and is intended only for laboratory research.
Are these metabolic research peptides intended for human use?
No. Every compound described here is supplied for research use only and is not intended for human consumption, self-administration, or therapeutic use. Handling should follow standard laboratory safety practices.
References and Further Reading
- Drucker DJ and colleagues, foundational reviews of incretin hormone biology and GLP-1 receptor signaling. PubMed: GLP-1 receptor signaling metabolism
- Preclinical literature on dual incretin (GIP and GLP-1) receptor agonists. PubMed: dual incretin receptor agonist preclinical
- Research on triple receptor agonists engaging GIP, GLP-1, and glucagon receptors. PubMed: triple agonist GIP GLP-1 glucagon receptor
- Studies of amylin and amylin analog signaling through amylin and calcitonin receptor complexes. PubMed: amylin analog receptor signaling
- Lee C, Cohen P and colleagues, characterization of the mitochondrial-derived peptide MOTS-c and AMPK. PubMed: MOTS-c mitochondrial peptide AMPK
- Preclinical and in-vitro research on the growth-hormone fragment AOD-9604 and lipid metabolism. PubMed: AOD-9604 lipid metabolism
- Reviews of mitochondrial-derived peptides and cellular energy regulation. PubMed: mitochondrial derived peptides metabolism
